- Home
- IKT vs WNEB Comparison
IKT vs WNEB Comparison
Compare IKT & WNEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IKT
- WNEB
- Stock Information
- Founded
- IKT 2008
- WNEB 1853
- Country
- IKT United States
- WNEB United States
- Employees
- IKT N/A
- WNEB N/A
- Industry
- IKT Biotechnology: Pharmaceutical Preparations
- WNEB Savings Institutions
- Sector
- IKT Health Care
- WNEB Finance
- Exchange
- IKT Nasdaq
- WNEB Nasdaq
- Market Cap
- IKT 159.2M
- WNEB 165.5M
- IPO Year
- IKT 2020
- WNEB N/A
- Fundamental
- Price
- IKT $3.21
- WNEB $8.80
- Analyst Decision
- IKT Strong Buy
- WNEB Hold
- Analyst Count
- IKT 1
- WNEB 3
- Target Price
- IKT $5.00
- WNEB $8.50
- AVG Volume (30 Days)
- IKT 318.4K
- WNEB 29.4K
- Earning Date
- IKT 11-12-2024
- WNEB 10-23-2024
- Dividend Yield
- IKT N/A
- WNEB 3.17%
- EPS Growth
- IKT N/A
- WNEB N/A
- EPS
- IKT N/A
- WNEB 0.52
- Revenue
- IKT $79,570.00
- WNEB $72,500,000.00
- Revenue This Year
- IKT N/A
- WNEB N/A
- Revenue Next Year
- IKT N/A
- WNEB $6.24
- P/E Ratio
- IKT N/A
- WNEB $17.11
- Revenue Growth
- IKT N/A
- WNEB N/A
- 52 Week Low
- IKT $0.80
- WNEB $6.00
- 52 Week High
- IKT $3.82
- WNEB $9.25
- Technical
- Relative Strength Index (RSI)
- IKT 76.96
- WNEB 54.27
- Support Level
- IKT $2.56
- WNEB $8.59
- Resistance Level
- IKT $2.75
- WNEB $9.11
- Average True Range (ATR)
- IKT 0.27
- WNEB 0.18
- MACD
- IKT 0.03
- WNEB 0.01
- Stochastic Oscillator
- IKT 96.43
- WNEB 59.26
About IKT Inhibikase Therapeutics Inc.
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease ("PD"), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.
About WNEB Western New England Bancorp Inc.
Western New England Bancorp Inc through its bank subsidiary, provides a range of financial services to individuals and companies in western Massachusetts and northern Connecticut. These services include commercial lending, residential lending and consumer lending, checking, savings and time deposits, cash management, and wealth management. Substantially all of the Company's revenues, profits, and assets are derived by the Bank from banking products and services.